The role of antimicrobials in Crohn's disease

Expert Review of Gastroenterology and Hepatology

Volumn 7, Issue 3, 2013, Pages 281-288

  Kale Pradhan, Pramodini B ^a,b   Zhao, Jing J ^a,c   Palmer, Jennifer R ^d   Wilhelm, Sheila M ^a,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

^d Leamington District Memorial Hospital   (Canada)

Author keywords

antimicrobials; ciprofloxacin; clarithromycin; Crohn's disease; metronidazole; rifaximin

Indexed keywords

ANTIINFECTIVE AGENT; BUDESONIDE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; INFLIXIMAB; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; ORNIDAZOLE; PLACEBO; PREDNISONE; RIFAXIMIN; SALAZOSULFAPYRIDINE;

ANTIMICROBIAL THERAPY; ANUS FISTULA; CLOSTRIDIUM DIFFICILE INFECTION; COLON; COLON CROHN DISEASE; CROHN DISEASE; DOSAGE SCHEDULE COMPARISON; DRUG RESPONSE; GASTROINTESTINAL SYMPTOM; HUMAN; ILEOCOLIC RESECTION; INTESTINE RESECTION; LOW DRUG DOSE; RECURRENT DISEASE; REMISSION; REVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CLARITHROMYCIN; CROHN DISEASE; HUMANS; METRONIDAZOLE; RECURRENCE; REMISSION INDUCTION; RIFAMYCINS; TREATMENT OUTCOME;

EID: 84874636414     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.13.6     Document Type: Review

References (26)

1. Prantera C, Scribano ML. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how. Curr. Opin. Gastroenterol. 25(4), 329-333 (2009).
2. Abraham C, Cho JH. Inflammatory bowel disease. N. Engl. J. Med. 361(21), 2066-2078 (2009).
3. Macfarlane S, Steed H, Macfarlane GT. Intestinal bacteria and inflammatory bowel disease. Crit. Rev. Clin. Lab. Sci. 46(1), 25-54 (2009).
4. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70(3), 439-444 (1976).
5. Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Am. J. Gastroenterol. 104(2), 465-483; quiz 464, 484 (2009).
6. Blichfeldt P, Blomhoff JP, Myhre E, Gjone E. Metronidazole in Crohn's disease. A double blind cross-over clinical trial. Scand. J. Gastroenterol. 13(1), 123-127 (1978).
7. Sutherland L, Singleton J, Sessions J et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 32(9), 1071-1075 (1991).
8. Rosén A, Ursing B, Alm T et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations. Gastroenterology 83(3), 541-549 (1982).
9. Ursing B, Alm T, Bárány F et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result. Gastroenterology 83(3), 550-562 (1982).
10. Ambrose NS, Allan RN, Keighley MR et al. Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. A prospective randomized study. Dis. Colon Rectum 28(2), 81-85 (1985).
11. Arnold GL, Beaves MR, Pryjdun VO, Mook WJ. Preliminary study of ciprofloxacin in active Crohn's disease. Inflamm. Bowel Dis. 8(1), 10-15 (2002).
12. West RL, Van Der Woude CJ, Hansen BE et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebocontrolled study. Aliment. Pharmacol. Ther. 20(11-12), 1329-1336 (2004).
13. Colombel JF, Lémann M, Cassagnou M et al. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am. J. Gastroenterol. 94(3), 674-678 (1999).
14. Thia KT, Mahadevan U, Feagan BG et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm. Bowel Dis. 15(1), 17-24 (2009).
15. Steinhart AH, Feagan BG, Wong CJ et al. Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial. Gastroenterology 123(1), 33-40 (2002).
16. Prantera C, Zannoni F, Scribano ML et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am. J. Gastroenterol. 91(2), 328-332 (1996).
17. Leiper K, Martin K, Ellis A, Watson AJ, Morris AI, Rhodes JM. Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease. Aliment. Pharmacol. Ther. 27(12), 1233-1239 (2008).
18. Prantera C, Lochs H, Campieri M et al. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment. Pharmacol. Ther. 23(8), 1117-1125 (2006).
19. Prantera C, Lochs H, Grimaldi M, Danese S, Scribano ML, Gionchetti P; Retic Study Group (Rifaximin-Eir Treatment in Crohn's Disease). Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. Gastroenterology 142(3), 473-481. e4 (2012).
20. Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108(6), 1617-1621 (1995).
21. Rutgeerts P, Van Assche G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebocontrolled trial. Gastroenterology 128(4), 856-861 (2005).
22. Khan KJ, Ullman TA, Ford AC et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and metaanalysis. Am. J. Gastroenterol. 106(4), 661-673 (2011).
23. Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease. Aliment. Pharmacol. Ther. 31(8), 802-809 (2010).
24. Bernstein LH, Frank MS, Brandt LJ, Boley SJ. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79(2), 357-365 (1980).
25. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 83(2), 383-387 (1982).
26. Jakobovits J, Schuster MM. Metronidazole therapy for Crohn's disease and associated fistulae. Am. J. Gastroenterol. 79(7), 533-540 (1984).